Cargando…
Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer In Vivo and In Vitro
The rising incidence of cholangiocarcinoma (CCA) coupled with a low 5‐year survival rate that remains below 10% delineates the urgent need for more effective treatment strategies. Although several recent studies provided detailed information on the genetic landscape of this fatal malignancy, versati...
Autores principales: | Saborowski, Anna, Wolff, Katharina, Spielberg, Steffi, Beer, Benedikt, Hartleben, Björn, Erlangga, Zulrahman, Becker, Diana, Dow, Lukas E., Marhenke, Silke, Woller, Norman, Unger, Kristian, Schirmacher, Peter, Manns, Michael P., Marquardt, Jens U., Vogel, Arndt, Saborowski, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396372/ https://www.ncbi.nlm.nih.gov/pubmed/30859153 http://dx.doi.org/10.1002/hep4.1312 |
Ejemplares similares
-
Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer
por: Erlangga, Zulrahman, et al.
Publicado: (2019) -
p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury Model
por: Buitrago-Molina, Laura Elisa, et al.
Publicado: (2021) -
FGFR inhibitors in cholangiocarcinoma: what’s now and what’s
next?
por: Saborowski, Anna, et al.
Publicado: (2020) -
A modular and flexible ESC-based mouse model of pancreatic cancer
por: Saborowski, Michael, et al.
Publicado: (2014) -
Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research
por: Erice, Oihane, et al.
Publicado: (2019)